RAI
Showing 1 - 25 of 648
Thyroid Disease Trial in Syracuse (SPECT)
Enrolling by invitation
- Thyroid Disease
- SPECT
-
Syracuse, New YorkSUNY Upstate Medical University
Aug 31, 2023
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)
Not yet recruiting
- Differentiated Thyroid Cancer
- +3 more
- Larotrectinib monotherapy
- 131I therapy
- (no location specified)
Mar 13, 2023
Serum Retinoic Acid Induced Protein 14 and Metastasis Associated
Not yet recruiting
- Breast Cancer
- laboratory test (RAI14 and MACC-1 )
- (no location specified)
Oct 18, 2023
Recurrence in Patients With Differentiated Thyroid Cancer
Not yet recruiting
- Differentiated Thyroid Cancer
- RAI
- (no location specified)
Nov 30, 2023
Differentiated Thyroid Cancer Patients Treated With Different
Not yet recruiting
- Thyroid Cancer
- RAI
- (no location specified)
Nov 15, 2023
Thyroid Carcinoma Trial in New York (Vemurafenib, serial 124I PET/CT, thyrotropin alpha)
Active, not recruiting
- Thyroid Carcinoma
- Vemurafenib
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 28, 2022
Targeted Therapy to Increase RAI Uptake in Metastatic PTC
Recruiting
- Papillary Thyroid Cancer
- Pediatric Cancer
- Whole body scan
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 11, 2022
Thyroid Cancer Trial in Beijing (Anlotinib HCl, Sodium Iodide I 131, Penpulimab)
Recruiting
- Thyroid Cancer
- Anlotinib hydrochloride
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Jan 18, 2022
Traumatic Brain Injury Trial in Midlothian (Resilience/Adjustment Counseling, Resilience/Adjustment Counseling with Booster
Recruiting
- Traumatic Brain Injury
- Resilience/Adjustment Counseling
- Resilience/Adjustment Counseling with Booster Sessions
-
Midlothian, VirginiaJennifer H Marwitz
Feb 2, 2022
Thyroid Cancer Trial in United States (Durvalumab (Medi4736), Radioiodine (RAI))
Active, not recruiting
- Thyroid Cancer
- Durvalumab (Medi4736)
- Radioiodine (RAI)
-
Basking Ridge, New Jersey
- +6 more
Jan 25, 2022
Rural South and Southeast Asia Household Health Survey
Recruiting
- Noncommunicable Disease
- +3 more
-
Dhaka, Bangladesh
- +3 more
Jan 5, 2023
Thyroid Cancer, Intermediate Risk Trial in France (Systematic RAI-treatment, Decision of RAI-treatment guided by a
Recruiting
- Thyroid Cancer
- Intermediate Risk
- Systematic RAI-treatment
- Decision of RAI-treatment guided by a post-operative assessment
-
Angers, France
- +26 more
Jul 26, 2022
Febrile Illness in Health Facilities in Rural South and
Recruiting
- Acute Febrile Illness
-
Dhaka, Bangladesh
- +3 more
Dec 13, 2022
Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)
Not yet recruiting
- Thyroid Cancer
- +5 more
- Selpercatinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022
Recurrent Thyroid Cancer Trial in Baltimore (Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive
Recruiting
- Recurrent Thyroid Cancer
- Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive iodine (RAI)
-
Baltimore, MarylandThe Johns Hopkins SKCCC
May 25, 2022
Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Neonatal Sepsis Trial in Cincinnati (Renal Angina Index (RAI))
Not yet recruiting
- Acute Kidney Injury
- +2 more
- Renal Angina Index (RAI)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 25, 2023
Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)
Active, not recruiting
- Differentiated Thyroid Cancer (DTC)
- Poorly Differentiated Thyroid Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Oct 7, 2021
Graves Disease Trial in Hong Kong (Echopulse)
Completed
- Graves Disease
- Echopulse
-
Hong Kong, Hong KongQueen Mary Hospital
May 17, 2022
Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,
Active, not recruiting
- Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
- Trametinib
- +3 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Sep 27, 2021
HPV Infection and Cervical Lesions in HIV Infected Thailand: A
Completed
- Cervical Cancer
-
Chanthaburi, Chantaburi, Thailand
- +23 more
Oct 20, 2021
Occurrence of Hypothyroidism in Patients Treated With RAI for
Active, not recruiting
- Nodule Solitary Thyroid
- +2 more
- radioacive iodine therapy
-
Brussels, BelgiumUniversitair Ziekenhuis Brussel
Apr 14, 2021
Acute Otitis Media (AOM) Trial in Thailand (V114, Pediatric vaccines)
Active, not recruiting
- Acute Otitis Media (AOM)
- V114
- Pediatric vaccines
-
Bangkok, Krung Thep Maha Nakhon, Thailand
- +12 more
Aug 17, 2022
Thyroid Cancer Trial in Boston (Nivolumab, Ipilimumab)
Active, not recruiting
- Thyroid Cancer
-
Boston, MassachusettsDana Farber Cancer Institute
Feb 18, 2022
Defining Causes of Deaths in South and Southeast Asia
Recruiting
- Cause of Mortality
- +4 more
- verbal autopsy interview
-
Dhaka, Bangladesh
- +4 more
Jan 18, 2023
Scrub Typhus Trial in Mae Sot, Chiang Rai (Doxycycline 7 days, Doxycycline 3 days, Azithromycin 3 days)
Recruiting
- Scrub Typhus
- Doxycycline 7 days
- +2 more
-
Mae Sot, Tak, Thailand
- +1 more
Mar 22, 2022